<DOC>
	<DOCNO>NCT02967731</DOCNO>
	<brief_summary>This Phase I , exploratory safety study 480 Biomedical Mometasone Furoate Sinus Drug Depot adult subject chronic sinusitis .</brief_summary>
	<brief_title>480 Biomedical Sinus Drug Depot</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Diagnosis CS . Female study subject childbearing potential must negative pregnancy test must agree become pregnant course study . The study subject inform nature study , agree provision provide write informed consent approve ethic committee respective clinical site . The study subject agree comply study requirement Known history intolerance corticosteroid . Oralsteroid dependent condition . Having corticosteroid potential systemic effect ( e.g. , oral , parenteral , high dose topical ) 1 month prior screen visit . Subjects acute chronic intracranial orbital complication chronic rhinosinusitis ( e.g. , brain abscess , relate problem eyes central nervous system ) . Known history hypothalamic pituitary adrenal ( HPA ) axial dysfunction morning serum cortisol level screen outside normal range . Previous pituitary adrenal surgery . History diagnosis ( either eye ) glaucoma , ocular hypertension , cataract . Recent participation another clinical trial within 1 month screen visit . Subjects currently participate investigational drug device study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>